Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Symptomatic slow-acting drugs (chondroprotectors) as different dosage forms have widespread application in the treatment of osteoarthrosis (OA) at different locations. The literature review considers their possible effect on carbohydrate metabolism, which is particularly important due to the high prevalence of diabetes mellitus in patients with OA. Current clinical recommendations for the use of chondroprotectors in the therapy of OA are given.


S M Noskov, A A Lavrukhina, K Yu Shirokova, A A Pryanichnikova. Strategy for the use of chondroprotectors in osteoarthrosis]. TerapevticheskiÄ­ arkhiv. 2013;85(5):92-4

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 23819346

View Full Text